Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription Articles published in Am J Kidney Dis Retrieve available abstracts of 30 articles: HTML format

Single Articles

June 2025
1. CHUNG EY, Carter SA, Jaure A, Howell M, et al
   Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study.
   Am J Kidney Dis. 2025 Jun 17:S0272-6386(25)00908.
   PubMed     Abstract available
   
   
   May 2025
2. 
   Erratum regarding "Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases" (Am J Kidney Dis. 2024;84(6):791-797).
   Am J Kidney Dis. 2025;85:666.
   PubMed    
   
   
   March 2025
3. MORELLE J, Aydin S, Debiec H, Demoulin N, et al
   Mass Spectrometry With Data-Independent Acquisition for the Identification of Target Antigens in Membranous Nephropathy.
   Am J Kidney Dis. 2025 Mar 7:S0272-6386(25)00717.
   PubMed     Abstract available
   
   
   
4. BU L, Valeri AM, Said SM, Zhu Y, et al
   IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series.
   Am J Kidney Dis. 2025 Mar 6:S0272-6386(25)00712.
   PubMed     Abstract available
   
   
   September 2024
5. FRIMAT M, Maanaoui M, Schwotzer N, Lebas C, et al
   Non-Plasmapheresis Approaches for Managing Severe Renal Thrombotic Microangiopathy: A Report of 7 Cases.
   Am J Kidney Dis. 2024 Sep 27:S0272-6386(24)00978.
   PubMed     Abstract available
   
   
   
6. FISCHMAN CJ, Holzman LB
   Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease.
   Am J Kidney Dis. 2024 Sep 18:S0272-6386(24)00972.
   PubMed    
   
   
   
7. ZENI L, Mescia F, Toso D, Dordoni C, et al
   Clinical Significance of the Cystic Phenotype in Alport Syndrome.
   Am J Kidney Dis. 2024;84:320-328.
   PubMed     Abstract available
   
   
   August 2024
8. DE COS M, Mosoyan G, Chauhan K, Troost JP, et al
   Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
   Am J Kidney Dis. 2024;84:205-214.
   PubMed     Abstract available
   
   
   
9. VON SAMSON-HIMMELSTJERNA FA, Kakavand N, Voran JC, Kolbrink B, et al
   Use of Immunoadsorption and Plasma Exchange for Treating Anti-Glomerular Basement Membrane Disease: Clinical Experience in Germany.
   Am J Kidney Dis. 2024;84:255-258.
   PubMed    
   
   
   July 2024
10. VOLPI S, Angelotti ML, Palazzini G, Antonelli G, et al
    Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Mutations: Report of Three Cases.
    Am J Kidney Dis. 2024 Jul 24:S0272-6386(24)00892.
    PubMed     Abstract available
    
    
    
11. IVKOVIC V, Kronbichler A, Caza TN
    "Atypical" Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?
    Am J Kidney Dis. 2024;84:127-129.
    PubMed    
    
    
    
12. CHAUVEAU B, Gibier JB, Rabant M
    In Reply to "'Atypical' Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?".
    Am J Kidney Dis. 2024;84:129.
    PubMed    
    
    
    June 2024
13. NAKAYAMA T, Kaneko H, Suzuki Y, Okada A, et al
    Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study.
    Am J Kidney Dis. 2024 Jun 19:S0272-6386(24)00832.
    PubMed     Abstract available
    
    
    
14. CORNELL LD
    Anti-Glomerular Basement Membrane Disease: Broadening the Spectrum.
    Am J Kidney Dis. 2024;83:701-703.
    PubMed    
    
    
    
15. CHAUVEAU B, Gibier JB, Olagne J, Morel A, et al
    Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
    Am J Kidney Dis. 2024;83:713-728.
    PubMed     Abstract available
    
    
    May 2024
16. SASAKI T, Tsuboi N
    Time-Varying Proteinuria in Predicting Outcome of IgA Nephropathy.
    Am J Kidney Dis. 2024 May 11:S0272-6386(24)00755.
    PubMed    
    
    
    March 2024
17. HONDA D, Okunaga I, Omote D, Inoue H, et al
    Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
    Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
    PubMed     Abstract available
    
    
    February 2024
18. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    PubMed     Abstract available
    
    
    January 2024
19. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    PubMed     Abstract available
    
    
    
20. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    PubMed    
    
    
    
21. PAUEKSAKON P, Najafian B, Alpers CE, Fogo AB, et al
    AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
    Am J Kidney Dis. 2024;83:e1-e2.
    PubMed    
    
    
    
22. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    PubMed     Abstract available
    
    
    December 2023
23. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    PubMed     Abstract available
    
    
    
24. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    PubMed     Abstract available
    
    
    
25. CANNEY M, Gunning HM, Johnston JC, Induruwage D, et al
    Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Am J Kidney Dis. 2023;82:725-736.
    PubMed     Abstract available
    
    
    September 2023
26. PODESTA MA, Trillini M, Portalupi V, Gennarini A, et al
    Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy.
    Am J Kidney Dis. 2023 Sep 28:S0272-6386(23)00838.
    PubMed     Abstract available
    
    
    
27. CASTER DJ, Lafayette RA
    The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Am J Kidney Dis. 2023 Sep 22:S0272-6386(23)00831.
    PubMed     Abstract available
    
    
    
28. AFOLABI H, Zhang BM, O'Shaughnessy M, Chertow GM, et al
    The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Am J Kidney Dis. 2023 Sep 18:S0272-6386(23)00797.
    PubMed     Abstract available
    
    
    
29. KEARNEY AO, Lerma E, Lin J
    Building Towards Clinical Translation: New Study Refines Genetic Architecture of IgA Nephropathy.
    Am J Kidney Dis. 2023 Sep 14:S0272-6386(23)00794.
    PubMed    
    
    
    
30. ELEY S, Morales-Alvarez MC, Vanguri VK, Chopra B, et al
    An Unusual Case of Anti-Glomerular Basement Membrane Disease and PLA2R-Associated Membranous Nephropathy After Exposure to Hydrocarbons.
    Am J Kidney Dis. 2023 Sep 13:S0272-6386(23)00793.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.